LIVING WITH CRC
Oxaliplatin-Induced Neuropathy Tracked in Survivors Up to 2 Years Post-TreatmentA prospective study of 106 stage II-III colon cancer patients treated with adjuvant CAPOX examined associations between oxaliplatin dosing and chemotherapy-induced peripheral neuropathy, with assessments continuing up to 24 months after treatment. (International Journal of Cancer)